TRAF7 in signaling and disease: emerging mechanisms and clinical implications
Albert Orock(University of Oklahoma Health Sciences Center), Ian F. Dunn(University of Oklahoma), Anthony C. Johnson(University of Oklahoma Health Sciences Center), Alla V. Tsytsykova(Boston Children's Hospital), Stefano Tarantini(Semmelweis University), Erdyni N. Tsitsikov(Harvard University), Sherwin Tavakol(University of Oklahoma Health Sciences Center), Jennifer Ihuoma(University of Oklahoma Health Sciences Center), Yufeng Liu(Xijing Hospital), Khanh Phan(University of Oklahoma Health Sciences Center), Jeffrey Zuccato(University of Oklahoma)
Cited by 1
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
|CNS Neuroscience & Therapeutics|2015|386
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
|Nature Medicine|2020|270
Activation of Colonic Mucosal 5-HT4 Receptors Accelerates Propulsive Motility and Inhibits Visceral Hypersensitivity
|Gastroenterology|2012|268
Gastrointestinal Physiology and Function
|Handbook of experimental pharmacology|2017|236